Jim Jones Deputy Commissioner for Human Foods of FDA | Official Website
Jim Jones Deputy Commissioner for Human Foods of FDA | Official Website
This is a 37.5% increase over the number of companies inspected in the previous year, when eight companies were inspected through nine inspections.
Most of the companies inspected were involved in the Food/Cosmetics, Devices, and Biologics sectors. The second most common type of company inspected in the time period worked in the Drugs sector.
There were 10 companies in line with FDA regulations who don’t need to adjust their management operations or regulatory/administrative actions (90.9%). One should take voluntary action to correct the organization's management operations (9.1%).
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
A. B. Munroe Dairy, Inc. | Food/Cosmetics | 05/23/2023 | No Action Indicated (NAI) |
Biomat USA, Inc. | Biologics | 05/11/2023 | No Action Indicated (NAI) |
Brown Urology, Inc. | Biologics | 07/07/2023 | No Action Indicated (NAI) |
Chi Foods, LLC | Food/Cosmetics | 04/27/2023 | No Action Indicated (NAI) |
Contech Medical, Inc. | Devices | 08/17/2023 | Voluntary Action Indicated (VAI) |
Palagi's 2000, Inc. | Food/Cosmetics | 05/26/2023 | No Action Indicated (NAI) |
Peter A. Soukas, M.D. | Devices | 10/27/2023 | No Action Indicated (NAI) |
Providence Specialty Products, LLC | Food/Cosmetics | 05/24/2023 | No Action Indicated (NAI) |
Rhode Island Blood Center, A Division of New York Blood Center, Inc. | Biologics | 03/07/2023 | No Action Indicated (NAI) |
Richard Zienowicz, M.D. | Devices | 06/29/2023 | No Action Indicated (NAI) |
Women & Infants Hospital IRB | Biologics | 08/18/2023 | No Action Indicated (NAI) |
Women & Infants Hospital IRB | Devices | 08/18/2023 | No Action Indicated (NAI) |
Women & Infants Hospital IRB | Drugs | 08/18/2023 | No Action Indicated (NAI) |